AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

National HIV/AIDS and Aging Awareness Day: A Perspective from the National Institutes of Health

blog.aids.gov

Co-authored by Scott Proestel, M.D., Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH

On September 18, 2011, we mark the fourth observance of National HIV/AIDS and Aging Awareness Day. The remarkable success of antiretroviral therapies in prolonging the lives of HIV-infected individuals who have access to and can tolerate these drugs has

30 Years of AIDS Video: A Look Back from NIH’s Dr. Anthony Fauci

Dr. Fauci on 30 Years of AIDS

This has been a big year for the HIV community. One key event was June 5 — which marked 30 years since the first reported cases of AIDS in the United States. As one of the many efforts to recognize this important milestone, the U.S. Department of Health and Human Services (HHS) developed a series…

6th International AIDS Society Conference Underway This Week

IAS2011

This week, over 5,000 delegates from around the world are attending the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) in Rome, Italy. This biannual conference is the world’s largest open scientific conference on HIV/AIDS, and provides “a unique opportunity for the world’s leading scientists, clinicians, public health experts and…

The Future of the NIAID Clinical Trial Units

NIAID

As the National Institute of Allergy and Infectious Diseases (NIAID) moves forward to restructure its HIV/AIDS Clinical Trials Networks and include a new network focused on infectious diseases other than AIDS, the Clinical Trial Units (CTUs) will continue to play a critical role in establishing, developing, and implementing the networks’ scientific research agendas. Additionally, we…

FDA and FTC Act to Remove Fraudulent HIV and STD Products from the Market

STDTreatments

Last month the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases (STDs), including HIV/AIDS. Among the products targeted in the action are Medavir, Herpaflor, Viruxo, C-Cure, and Never An…

What You Missed: Open for Questions 30 Years of AIDS

30 Years of AIDS White House Chat

Yesterday, Surgeon General Dr. Regina Benjamin, Director of the White House Office of National AIDS Policy Jeffrey Crowley and Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, NIH, Dr. Carl Dieffenbach came to the White House for a special live chat on 30th anniversary of the AIDS epidemic….

FDA Approves Second New Treatment for Hepatitis C

blog.aids.gov

On May 23, the U.S. Food and Drug Administration (FDA) announced the approval of telaprevir for the treatment of chronic viral hepatitis C. According to the U.S. Centers for Disease Control and Prevention, chronic viral hepatitis C affects 3.2 million Americans. Left untreated, chronic viral hepatitis C can lead to cirrhosis, liver cancer, and unwitting…

Upcoming Event: NIH’s Dr. Fauci’s Talk “Thirty Years of HIV/AIDS: A Personal Journey”

Dr. Anthony Fauci

June 5, 2011 will mark 30 years since the first cases of AIDS were reported in the U.S. On Tuesday, May 31, at 2pm ET, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), will be giving a talk, “Thirty Years of HIV/AIDS:…